FMO6P: A Drug Target for Nucleoside Import and Biomarker for Diseases

Target Name: FMO6P

NCBI ID: G388714

FMO6P

Other Name(s): FMO6 | Flavin containing dimethylaniline monoxygenase 6, pseudogene | flavin containing dimethylaniline monoxygenase 6, pseudogene

FMO6P: A Drug Target for Nucleoside Import and Biomarker for Diseases

FMO6P, also known as N-acetyl-尾-D-maltoside (NABM), is a drug target and a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique structure and chemical properties make it an attractive target for small molecule inhibitors.

FMO6P is a nucleoside transport protein that plays a critical role in the transport of nucleosides across cell membranes. It is expressed in most tissues and cells and is involved in regulating the import of nucleosides into the cytoplasm. The cytoplasm is the space between the cells and the surrounding tissue, and it is here that the cell interacts with the environment and carries out various cellular processes.

FMO6P is a member of the family of transport proteins known as nucleoside transport proteins (NUPs). These proteins are involved in the transport of various nucleosides, including DNA, RNA, and proteins, across cell membranes. NUPs are classified into three subfamilies based on their mode of transport. The first subfamily includes proteins that transport nucleosides in a simple, unidirectional manner across the membrane, such as NABM. The second subfamily includes proteins that transport nucleosides in a reverse direction, such as NABT. The third subfamily includes proteins that transport nucleosides in a bidirectional manner across the membrane, such as NABK.

FMO6P is a type of NUP and is characterized by its unique structure. It consists of a nucleoside base, a five-carbon sugar base, and a phosphate group. The nucleoside base is the central structural unit of DNA and RNA and is composed of a sugar molecule, a phosphate group, and a nitrogenous base. The five-carbon sugar base is attached to the sugar molecule and is responsible for the sugar's structural integrity. The phosphate group is attached to the 5'-end of the sugar molecule and is responsible for the stability and regulation of the nucleoside base.

FMO6P is involved in regulating the import of nucleosides into the cytoplasm. Nucleosides are the building blocks of DNA and RNA and are essential for various cellular processes, including DNA replication, gene expression, and cellular signaling. However, nucleosides are also involved in various diseases , including cancer, neurodegenerative diseases, and autoimmune disorders. The import of nucleosides into the cytoplasm is a critical step in the regulation of these diseases.

FMO6P is a drug target because of its unique structure and the role it plays in the regulation of nucleoside import. Drugs that inhibit FMO6P activity have been shown to be effective in treating various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

FMO6P has also been shown to be a potential biomarker for several diseases. Its unique structure and the role it plays in the regulation of nucleoside import make it an attractive target for small molecule inhibitors. Drugs that inhibit FMO6P activity have been shown to be effective in treating various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

FMO6P is a drug target that has the potential to treat a wide range of diseases. Its unique structure and the role it plays in the regulation of nucleoside import make it an attractive target for small molecule inhibitors. Further research is needed to fully understand the role of FMO6P in the regulation of nucleoside import and to develop effective treatments for various diseases.

Protein Name: Flavin Containing Dimethylaniline Monoxygenase 6, Pseudogene

Functions: It is probable that this protein is only produced in very small quantity or not at all as the gene coding for it seems to be unable to produce full-length transcripts

The "FMO6P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FMO6P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets